We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+10%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+632.23%
AUM
$44.5B
AUM Growth
-$1.18B
Cap. Flow
-$4.15B
Cap. Flow %
-9.33%
Top 10 Hldgs %
9.83%
Holding
3,927
New
652
Increased
690
Reduced
847
Closed
1,055

Top Buys

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$309M
2
XOM icon
ExxonMobil
XOM
+$302M
3
AMZN icon
Amazon
AMZN
+$291M
4
C icon
Citigroup
C
+$253M
5
SHOP icon
Shopify
SHOP
+$238M

Top Sells

Rank Stock Value
1
HUM icon
Humana
HUM
+$383M
2
JNJ icon
Johnson & Johnson
JNJ
+$312M
3
JPM icon
JPMorgan Chase
JPM
+$285M
4
T icon
AT&T
T
+$191M
5
DG icon
Dollar General
DG
+$187M

Sector Composition

Rank Sector Weight
1 Healthcare 15.63%
2 Financials 15.61%
3 Technology 14.28%
4 Consumer Discretionary 13.21%
5 Industrials 5.23%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BCLI
2801
DELISTED
BRAINSTORM CELL THERAPUTC
BCLI
$61.6K ﹤0.01%
2,505
+1,637
+189% +$61.2K
PLG
2802
Platinum Group Metals
PLG
$193M
$61.3K ﹤0.01%
+35,225
New +$58.2K
SUP
2803
DELISTED
Superior Industries International
SUP
$60K ﹤0.01%
14,216
+3,600
+34% +$15.3K
NUVB icon
2804
Nuvation Bio
NUVB
$2.24B
$55.9K ﹤0.01%
29,111
ICD
2805
DELISTED
Independence Contract Drilling, Inc.
ICD
$55.8K ﹤0.01%
17,068
-7,197
-30% -$25.1K
OPTN
2806
DELISTED
OptiNose
OPTN
$55.2K ﹤0.01%
+1,989
New +$75.5K
ARC
2807
DELISTED
ARC Document Solutions, Inc.
ARC
$54.1K ﹤0.01%
18,468
-19,136
-51% -$50.7K
BNED icon
2808
Barnes & Noble Education
BNED
$435M
$52.4K ﹤0.01%
+299
New +$71.3K
IGV icon
2809
CALL
iShares Expanded Tech-Software Sector ETF
IGV
$14.9B
$51.2K ﹤0.01%
1,000
IGV icon
2810
PUT
iShares Expanded Tech-Software Sector ETF
IGV
$14.9B
$51.2K ﹤0.01%
1,000
-1,000
-50% -$51.8K
OXY icon
2811
CALL
Occidental Petroleum
OXY
$59B
$50.4K ﹤0.01%
800
-200
-20% -$13.6K
FNGR icon
2812
FingerMotion
FNGR
$18.3M
$43.7K ﹤0.01%
+15,552
New +$84.8K
LCTX icon
2813
Lineage Cell Therapeutics
LCTX
$283M
$43.4K ﹤0.01%
37,118
-6,709
-15% -$8.46K
OMF icon
2814
OneMain Financial
OMF
$7.32B
$43.3K ﹤0.01%
1,300
-15,500
-92% -$550K
CTXR icon
2815
Citius Pharmaceuticals
CTXR
$19.8M
$40.3K ﹤0.01%
+2,038
New +$55.6K
VZ icon
2816
CALL
Verizon
VZ
$196B
$39.4K ﹤0.01%
1,000
-9,200
-90% -$347K
ASHR icon
2817
CALL
Xtrackers Harvest CSI 300 China A-Shares ETF
ASHR
$1.58B
$39.2K ﹤0.01%
1,400
-344,400
-100% -$9.38M
NRDY icon
2818
Nerdy
NRDY
$94.9M
$38.7K ﹤0.01%
17,195
-89,486
-84% -$194K
MTBL
2819
DELISTED
Moatable, Inc. American Depositary Share (each representing forty-five (45) Class A Ordinary Shares)
MTBL
$36.5K ﹤0.01%
+22,833
New +$69.3K
KULR icon
2820
KULR Technology Group
KULR
$130M
$36.2K ﹤0.01%
+3,769
New +$46.5K
STXS icon
2821
Stereotaxis
STXS
$145M
$35.5K ﹤0.01%
+17,168
New +$33.5K
QUBT icon
2822
Quantum Computing Inc
QUBT
$2.02B
$35.2K ﹤0.01%
23,300
-15,966
-41% -$32.4K
YQ
2823
17 Education & Technology Group
YQ
$22.9M
$34.5K ﹤0.01%
+3,380
New +$19.4K
SISI
2824
DELISTED
Shineco
SISI
$34.4K ﹤0.01%
+1
New +$15.3K
AVAL icon
2825
Grupo Aval
AVAL
$6.23B
$32.4K ﹤0.01%
+12,800
New +$29.6K

Similar funds

Marshall Wace's Q4 2022 Portfolio in Review

As of Q4 2022, Marshall Wace held 3,927 positions worth $44.5B, down 2.6% from $45.6B the previous quarter. Its ten largest holdings account for 9.8% of the portfolio.

Marshall Wace withdrew a net $4.15B in Q4 2022, closing 1,055 positions and reducing 847 holdings. Its most notable exit was Humana, an estimated $383M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 15% a quarter earlier, followed by Financials and Technology.

Against the trend, Marshall Wace opened a new position in Elevance Health worth $188M.

  • Marshall Wace's largest Q4 2022 buy was Elevance Health: 366,649 shares worth $188M.
  • Marshall Wace added most to Biogen in Q4 2022, an estimated $309M increase.
  • Marshall Wace's biggest Q4 2022 reduction was Johnson & Johnson, cutting an estimated $312M.
  • Marshall Wace fully exited Humana in Q4 2022, selling an estimated $383M.
  • Marshall Wace's ten largest holdings make up 9.8% of its $44.5B portfolio in Q4 2022.
  • Marshall Wace opened 652 new positions and closed 1,055 in Q4 2022.
  • Marshall Wace's portfolio value fell 2.6% quarter-over-quarter to $44.5B.

Based on Marshall Wace's 13F filing for Q4 2022, filed 14 Feb 2023.